Publications by authors named "Simon Pledge"

Claim this Profile
O
Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Paul Tappenden, Sue Harnan, Shijie Ren, Praveen Thokala, Ruth Wong, Simon Pledge

Pharmacoeconomicsยท January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis